• Accueil >
  • Publications >
  • NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker

NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker

1 oct. 2020Modern Pathology

DOI : 10.1038/s41379-020-0542-z

Auteurs

Raul Perret, Julien Escuriol, Valérie Velasco, Laetitia Mayeur, Isabelle Soubeyran, Christophe Delfour, Sébastien Aubert, Marc Polivka, Marie Karanian, Alexandra Meurgey, Sophie Le Guellec, Noelle Weingertner, Sylvia Hoeller, Jean-Michel Coindre, Frédérique Larousserie, Gaëlle Pierron, Franck Tirode, François Le Loarer